674 related articles for article (PubMed ID: 28004107)
21. Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
Jin F; Gong QH; Xu YS; Wang LN; Jin H; Li F; Li LS; Ma YM; Shi JS
Int J Neuropsychopharmacol; 2014 Jun; 17(6):871-81. PubMed ID: 24513083
[TBL] [Abstract][Full Text] [Related]
22. Glibenclamide modulates microglial function and attenuates Aβ deposition in 5XFAD mice.
Ju YJ; Kim N; Gee MS; Jeon SH; Lee D; Do J; Ryu JS; Lee JK
Eur J Pharmacol; 2020 Oct; 884():173416. PubMed ID: 32721448
[TBL] [Abstract][Full Text] [Related]
23. Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.
Lee J; Chan SL; Mattson MP
Neuromolecular Med; 2002; 2(1):29-45. PubMed ID: 12230303
[TBL] [Abstract][Full Text] [Related]
24. Traumatic Brain Injury Increases the Expression of Nos1, Aβ Clearance, and Epileptogenesis in APP/PS1 Mouse Model of Alzheimer's Disease.
Miszczuk D; Dębski KJ; Tanila H; Lukasiuk K; Pitkänen A
Mol Neurobiol; 2016 Dec; 53(10):7010-7027. PubMed ID: 26671618
[TBL] [Abstract][Full Text] [Related]
25. Valproic acid alleviates memory deficits and attenuates amyloid-β deposition in transgenic mouse model of Alzheimer's disease.
Xuan AG; Pan XB; Wei P; Ji WD; Zhang WJ; Liu JH; Hong LP; Chen WL; Long DH
Mol Neurobiol; 2015 Feb; 51(1):300-12. PubMed ID: 24854198
[TBL] [Abstract][Full Text] [Related]
26. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
[TBL] [Abstract][Full Text] [Related]
27. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
[TBL] [Abstract][Full Text] [Related]
28. Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling.
Li L; Wu XH; Zhao XJ; Xu L; Pan CL; Zhang ZY
J Neuroinflammation; 2020 Feb; 17(1):61. PubMed ID: 32066466
[TBL] [Abstract][Full Text] [Related]
29. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
30. Selective Targeting of Class I HDAC Reduces Microglial Inflammation in the Entorhinal Cortex of Young APP/PS1 Mice.
Wang C; Shen D; Hu Y; Chen J; Liu J; Huang Y; Yu X; Chu H; Zhang C; Yin L; Liu Y; Ma H
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902234
[TBL] [Abstract][Full Text] [Related]
31. Quetiapine attenuates glial activation and proinflammatory cytokines in APP/PS1 transgenic mice via inhibition of nuclear factor-κB pathway.
Zhu S; Shi R; Li V; Wang J; Zhang R; Tempier A; He J; Kong J; Wang JF; Li XM
Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25618401
[TBL] [Abstract][Full Text] [Related]
32. Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model.
Jiao SS; Bu XL; Liu YH; Zhu C; Wang QH; Shen LL; Liu CH; Wang YR; Yao XQ; Wang YJ
Neurotox Res; 2016 Feb; 29(2):256-66. PubMed ID: 26707129
[TBL] [Abstract][Full Text] [Related]
33. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
34. The Aqueous Extract of
Kang CM; Bang JS; Park SY; Jung TW; Kim HC; Chung YH; Jeong JH
J Med Food; 2022 Oct; 25(10):943-951. PubMed ID: 36178947
[No Abstract] [Full Text] [Related]
35. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.
Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z
Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430
[TBL] [Abstract][Full Text] [Related]
36. Loss of Endothelial Nitric Oxide Synthase Promotes p25 Generation and Tau Phosphorylation in a Murine Model of Alzheimer's Disease.
Austin SA; Katusic ZS
Circ Res; 2016 Oct; 119(10):1128-1134. PubMed ID: 27601478
[TBL] [Abstract][Full Text] [Related]
37. Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease.
Lee HT; Lee KI; Chen CH; Lee TS
J Neuroinflammation; 2019 Dec; 16(1):267. PubMed ID: 31847859
[TBL] [Abstract][Full Text] [Related]
38. Wharton's Jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-β deposition in an APP/PS1 transgenic mouse model.
Xie ZH; Liu Z; Zhang XR; Yang H; Wei LF; Wang Y; Xu SL; Sun L; Lai C; Bi JZ; Wang XY
Clin Exp Med; 2016 Feb; 16(1):89-98. PubMed ID: 26188488
[TBL] [Abstract][Full Text] [Related]
39. Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation.
Gallagher JJ; Minogue AM; Lynch MA
Neurodegener Dis; 2013; 11(1):33-41. PubMed ID: 22627185
[TBL] [Abstract][Full Text] [Related]
40. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.
Go M; Kou J; Lim JE; Yang J; Fukuchi KI
Biochem Biophys Res Commun; 2016 Oct; 479(2):331-337. PubMed ID: 27641666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
